Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 30 May 2024

Mechanism of isorhynchophylline in lipopolysaccharide-induced acute lung injury based on proteomic technology

in Inflammation Pharmacology

Yaru Li
Junfeng Xing
Ling Qin
Chuanming Zhang
Zheng Yang
Min Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397498

2,309 views
2 citations

Original Research

Published on 30 May 2024

Melatonin modulates neuroinflammatory response and microglial activation in mice exposed to dim blue light at night

in Inflammation Pharmacology

Chao Song
Zhaotaize Suo
Zixu Wang
Jing Cao
Yulan Dong
Yaoxing Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1416350

4,893 views
15 citations

Review

Published on 30 May 2024

Recommendations for nutritional supplements for dry eye disease: current advances

in Inflammation Pharmacology

Ying Cong
Yibing Zhang
Yutong Han
Yunlong Wu
Dan Wang
Bingjie Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388787

18,279 views
13 citations

Original Research

Published on 28 May 2024

Sitagliptin ameliorates L-arginine-induced acute pancreatitis via modulating inflammatory cytokines expression and combating oxidative stress

in Inflammation Pharmacology

Heba M. Eltahir
Hossein M. Elbadawy
Mohannad A. Almikhlafi
Ali M. Alalawi
Ahmed J. Aldhafiri
Yaser M. Alahmadi
Sultan S. Al thagfan
Muayad Albadrani
Saber M Eweda
Mekky M. Abouzied

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389670

4,016 views
6 citations

Review

Published on 21 May 2024

The role of inflammation in central serous chorioretinopathy: From mechanisms to therapeutic prospects

in Inflammation Pharmacology

Xiao Shen
Fanhua Kong
Jing Wen
Xiao Wang
Chunlian Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1200492

4,718 views
7 citations

Editorial

Published on 17 May 2024

Editorial: Anti-inflammatory drug development focusing on immune mediated diseases

in Inflammation Pharmacology

José Fernando Oliveira-Costa
Amit Prasad

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413141

2,059 views

Review

Published on 17 May 2024

Emerging biologic frontiers for Sjogren’s syndrome: Unveiling novel approaches with emphasis on extra glandular pathology

in Inflammation Pharmacology

Xiao Xiao Li
Maierhaba Maitiyaer
Qing Tan
Wen Hui Huang
Yu Liu
Zhi Ping Liu
Yue Qiang Wen
Yu Zheng
Xing Chen
Rui Lin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377055

10,115 views
13 citations

Review

Published on 16 May 2024

Potential use of antioxidants for the treatment of chronic inflammatory diseases

in Inflammation Pharmacology

Alexander V. Blagov
Volha I. Summerhill
Vasily N. Sukhorukov
Elena B. Zhigmitova
Anton Y. Postnov
Alexander N. Orekhov

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1378335

9,501 views
51 citations

Original Research

Published on 14 May 2024

Hedgehog signaling is a promising target for the treatment of hepatic fibrogenesis: a new management strategy using itraconazole-loaded nanoparticles

in Inflammation Pharmacology

Elsayed A. Elmorsy
Sameh Saber
Ahmed Y. Kira
Abdullah Alghasham
Mohamed R. Abdel-Hamed
Maha M. Amer
Enas A. Mohamed
A AlSalloom A.
Abdullah S. Alkhamiss
Rabab S. Hamad

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377980

3,956 views
9 citations

Original Research

Published on 10 May 2024

Lobetyolin protects mice against LPS-induced sepsis by downregulating the production of inflammatory cytokines in macrophage

in Inflammation Pharmacology

Zhonghua Chen
Yixin Su
Jingtong Ding
Jia He
Lihua Lai
Yinjing Song

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1405163

4,932 views
14 citations

Review

Published on 10 May 2024

Inflammation and cancer: friend or foe?

in Inflammation Pharmacology

Andrés David Turizo-Smith
Samantha Córdoba-Hernandez
Lidy Vannessa Mejía-Guarnizo
Paula Stefany Monroy-Camacho
Josefa Antonia Rodríguez-García

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1385479

12,614 views
39 citations

Original Research

Published on 29 Apr 2024

Bergamottin (Ber) ameliorates the progression of osteoarthritis via the Sirt1/NF-κB pathway

in Inflammation Pharmacology

Guangjie Shen
Weihao Zhang
Qiming Tu
Juncheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389786

2,934 views
6 citations

Review

Published on 24 Apr 2024

Comparative efficacy of five approved Janus kinase inhibitors as monotherapy and combination therapy in patients with moderate-to-severe active rheumatoid arthritis: a systematic review and network meta-analysis of randomized controlled trials

in Inflammation Pharmacology

Wenting Cai
Rui Tong
Yue Sun
Yao Yao
Jinping Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387585

14,104 views
19 citations

Review

Published on 10 Apr 2024

Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?

in Inflammation Pharmacology

Diana V. Ávila-Martínez
Wendy K. Mixtega-Ruiz
José M. Hurtado-Capetillo
Oscar Lopez-Franco
Mónica Flores-Muñoz

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377113

3,686 views
2 citations

Systematic Review

Published on 10 Apr 2024

Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis

in Inflammation Pharmacology

Ting Yan
Ting Wang
Mei Tang
Nan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1372810

17,736 views
27 citations

Original Research

Published on 09 Apr 2024

Assessing the impact of body composition, metabolic and oxidative stress parameters on insulin resistance as a prognostic marker for reactive hypoglycemia: a cross-sectional study in overweight, obese, and normal weight individuals

in Inflammation Pharmacology

Maria Kościuszko
Angelika Buczyńska
Katarzyna Łuka
Ewa Duraj
Katarzyna Żuk-Czerniawska
Agnieszka Adamska
Katarzyna Siewko
Aleksandra Wiatr
Adam Jacek Krętowski
Anna Popławska-Kita

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1329802

2,673 views
4 citations

Editorial

Published on 05 Apr 2024

Editorial: Targeting immune cell metabolism in tissue fibrosis

in Inflammation Pharmacology

Dan Shan
Qianjiang Hu
Chao He
Yong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1400858

1,510 views

Original Research

Published on 21 Mar 2024

Novel mechanistic study of HDAC6 regulation of rheumatoid arthritis via CMA: exploring potential therapeutic targets

in Inflammation Pharmacology

Duoduo Lin
Weipeng Lai
Ningning Zheng
Hongbin Luo
Xiaole Chen
Wenzhong Que
Nanwen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1383663

3,025 views
5 citations

Original Research

Published on 21 Mar 2024

PPARδ agonist protects against osteoarthritis by activating AKT/mTOR signaling pathway-mediated autophagy

in Inflammation Pharmacology

Guantong Sun
Xiaodong Li
Pengcheng Liu
Yao Wang
Cheng Yang
Shuhong Zhang
Lei Wang
Xiaoqing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1336282

2,872 views
4 citations

Mini Review

Published on 18 Mar 2024

History and future perspectives of adipose tissue macrophage biology

in Inflammation Pharmacology

Tomonobu Kado
Ayumi Nishimura
Kazuyuki Tobe

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1373182

3,900 views
7 citations

Correction

Published on 13 Mar 2024

Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis

in Inflammation Pharmacology

Rasha Abdelhady
Sameh Saber
Mustafa Ahmed Abdel-Reheim
Mohannad Mohammad S. Alamri
Jaber Alfaifi
Masoud I. E. Adam
Lobna A. Saleh
Azza I. Farag
Elsayed A. Elmorsy
Hend S. El-Wakeel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1382529

1,923 views

Systematic Review

Published on 13 Mar 2024

Different biologics for biological-naïve patients with psoriatic arthritis: a systematic review and network meta-analysis

in Inflammation Pharmacology

Jixia Lin
Yougang Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1279525

7,680 views
6 citations

Clinical Trial

Published on 29 Feb 2024

Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action

in Inflammation Pharmacology

Paola Patrignani
Stefania Tacconelli
Annalisa Contursi
Elena Piazuelo
Annalisa Bruno
Stefania Nobili
Matteo Mazzei
Cristina Milillo
Ulrika Hofling
Gonzalo Hijos-Mallada

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362217

2,851 views
8 citations

Original Research

Published on 29 Feb 2024

Off-label use of Baricitinib improves moderate and severe atopic dermatitis in China through inhibiting MAPK and PI3K/Akt/mTOR pathway via targeting JAK-STAT signaling of CD4+ cells

in Inflammation Pharmacology

Shuang Chen
Caihua Li
Zeng Tu
Tao Cai
Xinying Zhang
Lei Wang
Ruoyuan Tian
Jinglan Huang
Yuxuan Gong
Xiaotong Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1324892

6,049 views
9 citations